The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated

Endocrinology

Volumn 141, Issue 12, 2000, Pages 4768-4776

  Gori, Francesca ^a   Hofbauer, Lorenz C ^a   Dunstan, Colin R ^b   Spelsberg, Thomas C ^a   Khosla, Sundeep ^a   Lawrence Riggs, B ^a  

^a MAYO CLINIC   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; BONE MARROW CELL; BONE REMODELING; CELL DIFFERENTIATION; CELL LINEAGE; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

EID: 0034522030     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.12.7840     Document Type: Article

References (48)

1. Remodeling dynamics
2. Osteonal and hemi-osteonal remodeling: The spiral and temporal framework for signal traffic in adult human bone
3. Osteoblastic cell lineage
4. Modulation of osteoclast differentiation
5. Advances in bone biology: The osteoclast
6. Parathyroid hormone stimulates bone formation and resorption in organ culture: Evidence for a coupling mechanism
7. Role of transforming growth factor-β in bone remodeling
8. Osteoblastic cells are involved in osteoclast formation
9. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence
10. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
11. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
12. Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
13. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
14. The effect of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage
15. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation
16. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
17. Identity of osteoclastogenesis factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
18. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic cells
19. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
20. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
21. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
22. RANK is the essential signaling receptor of osteoclast differentiation factor in osteoclastogenesis
23. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
24. Tumor necrosis receptor family member RANK mediated osteoclast differentiation and activation induced by osteoprotegerin ligand
25. A combination of osteoclast differentiation factor and macrophages-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
26. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma
27. Differentiation of human marrow stromal cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment and inhibits late adipocyte maturation
28. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanism of glucocorticoid-induced osteoporosis
29. Bone cell phosphotyrosine phosphate: Characterization and regulation by calcitropic hormones
30. Calcification
31. Development and characterization of a conditionally transformed adult human osteoblastic cell line
32. RNA molecular weight determination by gel electrophoresis under denaturating conditions, a critical reexamination
33. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulosa
34. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
35. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2 and cytokines
36. Differentiation of human bone marrow osteogenic stromal cells in vitro. Induction of the osteoblast phenotype by dexamethasone
37. Differentiation of muscle, fat, cartilage and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone
38. In vitro effects of growth factors and dexamethasone on rat marrow stromal cells
39. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell culture by dexamethasone and BMP-2
40. The role of ascorbic acid in mesenchymal differentiation
41. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation
42. Promotor structure of mouse RANKL/TRANCE/OPGL/ODF gene
43. Cytokines in the pathogenesis of osteoporosis
44. 2+ sensing in the regulation of osteoclastic bone resorption
45. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
46. The monoclonal antibodies 18d7/91f2 recognize a receptor regulatory protein on mouse bone marrow stromal cells
47. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β